Kết quả tìm kiếm - Matthias Christgen
- Đang hiển thị 1 - 20 kết quả của 24
- Chuyển đến trang tiếp theo
-
1
Lobular breast cancer: molecular basis, mouse and cellular models Bằng Matthias Christgen, Patrick W.B. Derksen
Được phát hành 2015Artigo -
2
Clinical validity and clinical utility of Ki67 in early breast cancer Bằng Hans Kreipe, Nadia Harbeck, Matthias Christgen
Được phát hành 2022Revisão -
3
-
4
-
5
-
6
E-cadherin to P-cadherin switching in lobular breast cancer with tubular elements Bằng Matthias Christgen, Stephan Bartels, Jana Lisa van Luttikhuizen, Janin Bublitz, Luisa Rieger, Henriette Christgen, Helge Stark, Bjoern Sander, Ulrich Lehmann, Doris Steinemann, Patrick W.B. Derksen, Hans Kreipe
Được phát hành 2020Artigo -
7
Atlas of Lobular Breast Cancer Models: Challenges and Strategic Directions Bằng George Sflomos, Koen Schipper, Thijs Koorman, Amanda Fitzpatrick, Steffi Oesterreich, Adrian V. Lee, Jos Jonkers, Valerie G. Brunton, Matthias Christgen, Clare M. Isacke, Patrick W.B. Derksen, Cathrin Brisken
Được phát hành 2021Revisão -
8
Association of TILs with clinical parameters, Recurrence Score® results, and prognosis in patients with early HER2-negative breast cancer (BC)—a translational analysis of the prosp... Bằng Kolberg-Liedtke, Cornelia, Oleg, Gluz, Fred, Heinisch, Friedrich, Feuerhake, Hans, Kreipe, Michael, Clemens, Benno, Nuding, Wolfram, Malter, Toralf, Reimer, Rachel, Wuerstlein, Monika, Graeser, Steve, Shak, Ulrike, Nitz, Ronald, Kates, Matthias, Christgen, Nadia, Harbeck
Được phát hành 2020Text -
9
Nuclear Kaiso Expression Is Associated with High Grade and Triple-Negative Invasive Breast Cancer Bằng Jeroen F. Vermeulen, Robert A. H. van de Ven, Cigdem Ercan, Petra van der Groep, Elsken van der Wall, Peter Bult, Matthias Christgen, Ulrich Lehmann, Juliet M. Daniel, P. J. van Diest, Patrick W.B. Derksen
Được phát hành 2012Artigo -
10
Afadin loss induces breast cancer metastasis through destabilisation of E‐cadherin to F‐actin linkage Bằng Max A. K. Rätze, Lotte Enserink, Noboru Ishiyama, Sven van Kempen, Christina H. J. Veltman, Isaäc J. Nijman, Wisse E. Haakma, Carlos Caldas, René Bernards, P. J. van Diest, Matthias Christgen, Thijs Koorman, Patrick W.B. Derksen
Được phát hành 2025Artigo -
11
Clinico-pathological characteristics of a distinct tumor phenotype: invasive lobular carcinoma with tubular elements (ILC-TE) in the WSG ADAPTcycle trial Bằng Martin Radner, Sandy Burmeister, Katarzyna Jóźwiak, Nora Schaumann, Malte Gronewold, Mieke Raap, Stephan Bartels, Henriette Christgen, Leonie Donata Kandt, Petra Hillmann, Ulrich Lehmann, Oleg Gluz, Monika Graeser, Sherko Kuemmel, Christine zu Eulenburg, Nadia Harbeck, Hans Kreipe, Matthias Christgen
Được phát hành 2025Artigo -
12
Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised phase 3 West Germa... Bằng Ulrike Nitz, Oleg Gluz, Matthias Christgen, Ronald Kates, Michael Clemens, Wolfram Malter, Benno Nuding, Bahriye Aktas, Sherko Küemmel, Toralf Reimer, Andrea Stefek, Fatemeh Lorenz-Salehi, Petra Krabisch, Marianne Just, Doris Augustin, Cornelia Liedtke, Calvin Chao, Steven Shak, Rachel Wuerstlein, Hans Kreipe, Nadia Harbeck
Được phát hành 2017Artigo -
13
Differential impact of prognostic parameters in hormone receptor–positive lobular breast cancer Bằng Matthias Christgen, Oleg Gluz, Nadia Harbeck, Ronald Kates, Mieke Raap, Henriette Christgen, Michael Clemens, Wolfram Malter, Benno Nuding, Bahriye Aktas, Sherko Küemmel, Toralf Reimer, Andrea Stefek, Petra Krabisch, Marianne Just, Doris Augustin, Monika Graeser, Frederick L. Baehner, Rachel Wuerstlein, Ulrike Nitz, Hans Kreipe
Được phát hành 2020Artigo -
14
De-escalation strategies in HER2-positive early breast cancer (EBC): final analysis of the WSG-ADAPT HER2+/HR− phase II trial: efficacy, safety, and predictive markers for 12 weeks... Bằng Ulrike Nitz, Oleg Gluz, Matthias Christgen, E.‐M. Grischke, Doris Augustin, Sherko Küemmel, Michael Braun, Jochem Potenberg, A. Kohls, Katja Krauss, Andrea Stefek, Claudia Schumacher, Helmut Forstbauer, Toralf Reimer, Hans Holger Fischer, C Liedtke, Rachel Wuerstlein, Johannes Schumacher, Ronald Kates, H. Kreipe, Nadia Harbeck
Được phát hành 2017Artigo -
15
Efficacy of deescalated chemotherapy according to PAM50 subtypes, immune and proliferation genes in triple‐negative early breast cancer: Primary translational analysis of the WSG‐A... Bằng Oleg Gluz, Cornelia Kolberg‐Liedtke, Aleix Prat, Matthias Christgen, Daniel Gebauer, Ronald Kates, Laia Paré, Eva‐Maria Grischke, Helmut Forstbauer, Michael Braun, Mathias Warm, John Hackmann, Christoph Uleer, Bahriye Aktas, Claudia Schumacher, Sherko Küemmel, Rachel Wuerstlein, Enrico Pelz, Ulrike Nitz, Hans Kreipe, Nadia Harbeck
Được phát hành 2019Artigo -
16
The impact of anthracyclines in intermediate and high-risk HER2-negative early breast cancer—a pooled analysis of the randomised clinical trials PlanB and SUCCESS C Bằng Amelie de Gregorio, Wolfgang Janni, Thomas W. P. Friedl, Ulrike Nitz, Brigitte Rack, Andreas Schneeweiß, Ronald Kates, Tanja Fehm, Hans Kreipe, Matthias Christgen, Sherko Kümmel, Elisabeth Trapp, Rachel Wuerstlein, Andreas D. Hartkopf, Michael Clemens, Toralf Reimer, Lothar Häberle, Peter A. Fasching, Oleg Gluz, Nadia Harbeck
Được phát hành 2022Artigo -
17
Efficacy of Endocrine Therapy Plus Trastuzumab and Pertuzumab vs De-escalated Chemotherapy in Patients with Hormone Receptor–Positive/<i>ERBB2</i>-Positive Early Breast Cancer Bằng Oleg Gluz, Ulrike Nitz, Matthias Christgen, Sherko Küemmel, Johannes Holtschmidt, Johannes Schumacher, Andreas Hartkopf, Jochem Potenberg, Kerstin Luedtke‐Heckenkamp, Marianne Just, Christian Schem, Raquel von Schumann, Cornelia Kolberg‐Liedtke, Christine zu Eulenburg, Timo Schinköthe, Monika Graeser, Rachel Wuerstlein, Ronald Kates, Hans Kreipe, Nadia Harbeck
Được phát hành 2023Artigo -
18
Evidence-based guidelines for managing patients with primary ER+ HER2− breast cancer deferred from surgery due to the COVID-19 pandemic Bằng Mitch Dowsett, Matthew J. Ellis, J. Michael Dixon, Oleg Gluz, J.F.R. Robertson, Ronald Kates, Vera J. Suman, Arran Turnbull, Ulrike Nitz, Matthias Christgen, Hans Kreipe, Sherko Küemmel, Judith M. Bliss, Peter Barry, Stephen Johnston, Samuel A. Jacobs, X. Cynthia, Ian E. Smith, Nadia Harbeck
Được phát hành 2020Artigo -
19
Integration of Pathological Criteria and Immunohistochemical Evaluation for Invasive Lobular Carcinoma Diagnosis: Recommendations From the European Lobular Breast Cancer Consortium Bằng Maxim De Schepper, Thijs Koorman, François Richard, Matthias Christgen, Anne Vincent‐Salomon, Stuart J. Schnitt, P. J. van Diest, Gitte Zels, Freya Mertens, Marion Maetens, Isabelle Vanden Bempt, Nadia Harbeck, Ulrike Nitz, Monika Gräser, Sherko Kümmel, Oleg Gluz, Birgit Weynand, Giuseppe Floris, Patrick W.B. Derksen, Christine Desmedt
Được phát hành 2024Artigo -
20
Comparison of Neoadjuvant Nab-Paclitaxel+Carboplatin vs Nab-Paclitaxel+Gemcitabine in Triple-Negative Breast Cancer: Randomized WSG-ADAPT-TN Trial Results Bằng Oleg Gluz, Ulrike Nitz, Cornelia Liedtke, Matthias Christgen, Eva‐Maria Grischke, Helmut Forstbauer, Michael Braun, Mathias Warm, John Hackmann, Christoph Uleer, Bahriye Aktas, Claudia Schumacher, Nikola Bangemann, Christoph Lindner, Sherko Küemmel, Michael Clemens, Jochem Potenberg, Peter Staib, A. Kohls, Raquel von Schumann, Ronald Kates, Ronald Kates, Johannes Schumacher, Rachel Wuerstlein, Hans Kreipe, Nadia Harbeck
Được phát hành 2017Artigo
Công cụ tìm kiếm:
Các môn học liên quan
Breast cancer
Cancer
Medicine
Internal medicine
Oncology
Biology
Pathology
Genetics
Invasive ductal carcinoma
Invasive lobular carcinoma
Cancer research
Chemotherapy
Cadherin
Cell
Immunohistochemistry
CDH1
Gene
Ductal carcinoma
Gynecology
Lobular carcinoma
Triple-negative breast cancer
Chemistry
Clinical trial
Confidence interval
Gastroenterology
Hazard ratio
Metastasis
Neoadjuvant therapy
Proportional hazards model
Trastuzumab